OCS
Oculis Holding AG - Ordinary shares (OCS)
$
50About Oculis Holding AG - Ordinary shares (OCS)
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.
Details
Daily high
$18.36
Daily low
$17.22
Price at open
$17.89
52 Week High
$23.08
52 Week Low
$10.79
Market cap
954.3M
Dividend yield
0.00%
Volume
30,675
Avg. volume
14,401
P/E ratio
-6.59
Oculis Holding AG - Ordinary shares News
Details
Daily high
$18.36
Daily low
$17.22
Price at open
$17.89
52 Week High
$23.08
52 Week Low
$10.79
Market cap
954.3M
Dividend yield
0.00%
Volume
30,675
Avg. volume
14,401
P/E ratio
-6.59